Globus Medical, Inc. (GMED)

Globus Medical Stock Forecast

Stock Price Forecast

The 13 analysts that cover Globus Medical stock have a consensus rating of "Buy" and an average price target of $94.3, which forecasts a 60.92% increase in the stock price over the next year. The lowest target is $68 and the highest is $115.

Price Target: $94.3 (+60.92%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$68	$94.3	$97	$115
Change	+16.04%	+60.92%	+65.53%	+96.25%

* Price targets were last updated on May 12, 2025.

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	5	4	4	4	3	3
Buy	5	5	5	5	5	5
Hold	3	4	4	4	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Turkaly JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 27, 2025
Ryan Zimmerman BTIG	BTIG	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 27, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $80 → $68	Hold	Maintains	$80 → $68	+16.04%	May 12, 2025
Matt O'Brien Piper Sandler	Piper Sandler	Buy Maintains $100 → $80	Buy	Maintains	$100 → $80	+36.52%	May 9, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $82 → $80	Hold	Maintains	$82 → $80	+36.52%	Apr 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.91B

Increased by 15.47%

from 2.52B

Revenue Next Year

3.17B

Increased by 8.97%

from 2.91B

EPS This Year

3.24

Increased by 331.60%

from 0.75

EPS Next Year

3.78

Increased by 16.92%

from 3.24

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	789.04M	958.10M	1.02B	1.57B	2.52B	2.91B	3.17B	3.39B
Revenue Growth	0.47%	21.43%	6.76%	53.35%	60.62%	15.47%	8.97%	6.85%
EPS	1.01	1.44	1.85	1.07	0.75	3.24	3.78	4.25
EPS Growth	-33.55%	42.57%	28.47%	-42.16%	-29.91%	331.60%	16.92%	12.30%
Forward PE	-	-	-	-	-	18.10	15.48	13.79
No. Analysts	-	-	-	-	-	16	16	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	3.0B	3.4B	3.6B
Avg	2.9B	3.2B	3.4B
Low	2.7B	2.9B	3.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	20.8%	16.5%	14.2%
Avg	15.5%	9.0%	6.8%
Low	8.6%	1.0%	-1.7%

EPS Forecast

EPS	2025	2026	2027	2028
High	3.53	4.23	4.81
Avg	3.24	3.78	4.25
Low	2.97	3.36	3.68

EPS Growth

EPS Growth	2025	2026	2027	2028
High	370.4%	30.7%	27.1%
Avg	331.6%	16.9%	12.3%
Low	295.9%	3.8%	-2.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.